MiMedx Group, Inc. (MDXG) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	355.2M	418.6M	348.9M	321.5M	267.8M
Cost of Revenue	75.1M	73.0M	60.1M	54.6M	48.3M
Gross Profit	280.1M	345.6M	288.8M	266.8M	219.5M
Operating Expenses
R&D Expense	15.4M	15.1M	12.3M	12.7M	12.7M
SG&A Expense	255.1M	266.2M	216.4M	216.3M	220.8M
General & Admin Expense	38.0M	—	—	—	—
Selling & Marketing Expense	144.0M	—	—	—	—
Other Expenses	704.0K	—	1.2M	762.0K	701.0K
Total Operating Expenses	271.2M	281.3M	229.9M	229.7M	234.3M
Cost and Expenses	346.4M	354.7M	290.0M	284.4M	282.6M
Operating Income (EBIT)	8.8M	63.9M	58.9M	37.1M	(14.7M)
Non-Operating
Interest Income	2.6M	4.7M	—	—	—
Interest Expense	1.6M	1.8M	1.0M	6.5M	5.0M
Net Interest Income	1.0M	2.9M	(1.0M)	(6.5M)	(5.0M)
Other Non-Op Income/Expense	2.8M	2.4M	(1.6M)	(6.5M)	(5.0M)
Non-Operating Income (excl Interest)	(3.3M)	(4.2M)	(446.0K)	26.0K	4.0K
EBT (Pre-Tax Income)	11.5M	66.3M	57.3M	30.6M	(19.7M)
Income Tax Expense	5.3M	17.7M	15.3M	(36.8M)	206.0K
Bottom Line
Net Income	6.2M	48.6M	42.4M	67.4M	(30.2M)
Earnings from Cont. Ops	6.2M	48.6M	42.0M	67.4M	(20.0M)
Earnings from Discont. Ops	—	—	421.0K	—	(10.2M)
Bottom Line Net Income	6.2M	48.6M	42.4M	55.8M	(36.8M)
Per Share
Basic EPS	$0.04	$0.33	$0.29	$0.48	($0.27)
Diluted EPS	$0.04	$0.32	$0.28	$0.38	($0.27)
Revenue Per Share	$2.40	$2.83	$2.37	$2.76	$2.37
Shares
Basic Shares Outstanding	147.8M	147.8M	147.0M	116.5M	112.9M
Diluted Shares Outstanding	147.8M	149.7M	149.0M	146.0M	112.9M
Profitability Metrics
EBITDA	23.7M	82.9M	65.4M	40.5M	(10.7M)
D&A	11.7M	14.9M	6.0M	3.4M	4.0M
EBIT	12.0M	68.0M	59.3M	37.1M	(14.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026